June 9, 2023

FDA approves first gene therapy for hemophilia B

On November 22, 2022, the FDA approved Hemgenix®, an adeno-associated virus vector-based gene therapy indicated for the treatment of adults with Hemophilia B (congenital Factor IX deficiency) who:

  • Currently use Factor IX (FIX) prophylaxis therapy, or
  • Have current or historical life-threatening hemorrhage, or
  • Have repeated, serious spontaneous bleed episodes

The HOC has individuals who expressed interest in Hemgenix, have completed their pre-screening eligibility and are in the final stages of meeting all the requirements needed for gene therapy The HOC medical team has participated in extensive educational trainings and are knowledgeable about all aspects of gene therapy with Hemgenix®. This includes, but is not limited to, preparation for treatment, administration of the therapy, and close monitoring once it has been given.

If you have any questions or want more information about Hemgenix®, please contact your hemophilia treatment center.

LEARN MORE ABOUT HEMGENIX®

Recent Posts

Navigating Sleep Challenges from Childhood to Adulthood

Today on Beyond the Bleeds, we're joined by Dr. Bridget Freeman to explore the importance of sleep health—why it’s foundational to our overall well-being, how our sleep patterns evolve throughout a lifetime, and what we can do to optimize sleep for physical, mental,...

Inside the World of Child Life Specialists with Chris Bivins

Today on Beyond the Bleeds, I’m joined by Chris Bivins, Child Life Specialist, to talk about the essential role Child Life professionals play in pediatric healthcare settings. We explore how Child Life Specialists help children and families navigate the challenges of...

Embracing Summer Safely with a Bleeding Disorder

Summer is a time to enjoy sunshine, vacations, and quality moments with friends and family. It’s a season filled with outdoor adventures, travel, and well-deserved relaxation. But for individuals living with bleeding disorders, summer also brings unique challenges...

Caring for Mental Health in the Bleeding Disorders Community

Living with a bleeding disorder affects more than just the body. It impacts emotional and psychological well-being, as well. Managing a chronic condition like hemophilia or von Willebrand disease often comes with daily stress, uncertainty, and limitations that can...

Empowering Choice: Dave’s Story

At Hemophilia Outreach Center, we're committed to more than just medicine — we're committed to people. Gene therapy is a groundbreaking treatment, but what makes it truly meaningful are the people behind it — the patients who face each day with courage, the care teams...

Life After Infusions: Mason’s Story

At Hemophilia Outreach Center, we're committed to more than just medicine — we're committed to people. Gene therapy is a groundbreaking treatment, but what makes it truly meaningful are the people behind it — the patients who face each day with courage, the care teams...

Social Media